Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sobrero

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapyC Aschele, D Debernardis, S Casazza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas)E Bolli, S Saccomanno, G Mondini, et al.
Advances in Enzyme Regulation|January 1, 1985
Methotrexate resistant cells as targets for selective chemotherapyJ R Bertino, E Mini, A Sobrero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerE Bajetta, M Colleoni, R Rosso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2011
Pancreatic cancer treatment and research: an international expert panel discussionM A Tempero, J Berlin, M Ducreux, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|January 28, 2006
[Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case]S Baldo, M Rivoire, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2015
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)N I Cherny, R Sullivan, U Dafni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancerA Sobrero, M T Nobile, A Guglielmi, et al.
British Journal of Cancer|September 24, 2004
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracilA Guglielmi, S Barni, A Zaniboni, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapyC Aschele, D Debernardis, S Casazza, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas)E Bolli, S Saccomanno, G Mondini, et al.
Advances in Enzyme Regulation|January 1, 1985
Methotrexate resistant cells as targets for selective chemotherapyJ R Bertino, E Mini, A Sobrero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinomaR Rosso, T Mazzei, A Sobrero, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerE Bajetta, M Colleoni, R Rosso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2011
Pancreatic cancer treatment and research: an international expert panel discussionM A Tempero, J Berlin, M Ducreux, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|January 28, 2006
[Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case]S Baldo, M Rivoire, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2015
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)N I Cherny, R Sullivan, U Dafni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancerA Sobrero, M T Nobile, A Guglielmi, et al.
British Journal of Cancer|September 24, 2004
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracilA Guglielmi, S Barni, A Zaniboni, et al.
Pageof 7